A real-world study of pegcetacoplan for treatment of geographic atrophy showed significantly better outcomes than the pivotal clinical trials in patients who had symptomatic vision loss.
Boehringer Ingelheim Pharma GmbH & Co. KG has synthesized NADPH oxidase 4 (NOX4) inhibitors reported to be useful for the treatment of atherosclerosis, cancer, pulmonary hypertension, inflammatory ...
Expert Rev Ophthalmol. 2013;8(5):475-484. Pazopanib (GlaxoSmithKline), a multi-kinase inhibitor, is currently being tested in clinical trials as a topical eye drop and tablet (Clinicaltrials.gov ...